NASDAQ:BGLC BioNexus Gene Lab (BGLC) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free BGLC Stock Alerts $0.61 -0.01 (-1.60%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$0.60▼$0.6350-Day Range$0.56▼$1.0752-Week Range$0.31▼$17.88Volume52,740 shsAverage Volume1.18 million shsMarket Capitalization$10.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get BioNexus Gene Lab alerts: Email Address Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. About BioNexus Gene Lab Stock (NASDAQ:BGLC)BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Read More BGLC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BGLC Stock News HeadlinesApril 26, 2024 | americanbankingnews.comAnalyzing Elekta AB (publ) (OTCMKTS:EKTAY) & BioNexus Gene Lab (NASDAQ:BGLC)April 23, 2024 | americanbankingnews.comAnalyzing BioNexus Gene Lab (NASDAQ:BGLC) & Renalytix (NASDAQ:RNLX)May 2, 2024 | Porter & Company (Ad)#1 election stockI’ve found the number one company to buy… Before either Trump or Biden wins in November. It all has to do with an overlooked executive order that Trump signed just days before leaving office… and that Biden has quietly hijacked for his own political power. April 19, 2024 | msn.comWhy Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day SessionApril 19, 2024 | investorplace.comWhy Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?April 18, 2024 | marketwatch.comBioNexus Gene Lab Invests in AI Healthcare CompanyApril 18, 2024 | globenewswire.comBioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareFebruary 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Short Interest ReportMay 2, 2024 | Porter & Company (Ad)#1 election stockI’ve found the number one company to buy… Before either Trump or Biden wins in November. It all has to do with an overlooked executive order that Trump signed just days before leaving office… and that Biden has quietly hijacked for his own political power. February 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Analyst Ratings, Price Targets, PredictionsFebruary 14, 2024 | finance.yahoo.comCompanies Like BioNexus Gene Lab (NASDAQ:BGLC) Can Afford To Invest In GrowthDecember 20, 2023 | nasdaq.comBioNexus Gene Lab Corp Common stock (BGLC)November 22, 2023 | seekingalpha.comBGLC BioNexus Gene Lab Corp.October 16, 2023 | sg.finance.yahoo.comBioNexus Gene Lab Corp. (BGLC)August 23, 2023 | markets.businessinsider.comWhy Is BioNexus Gene Lab (BGLC) Stock Up 33% Today?July 28, 2023 | investing.comBioNexus Gene Lab Corp (BGLC)July 24, 2023 | seekingalpha.comIPO Roundup: Surf Air Mobility, Opti-Harvest and moreJuly 24, 2023 | finanznachrichten.deBIONEXUS GENE LAB CORPJuly 24, 2023 | finance.yahoo.comBioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital MarketJuly 21, 2023 | morningstar.comBioNexus Gene Lab Corp Ordinary SharesJuly 21, 2023 | msn.comInvestors Look to Close Week on Positive Note as US Futures See Mixed Performance Premarket FridayJuly 21, 2023 | investorplace.comWhy Is BioNexus Gene Lab (BGLC) Stock Up 64% Today?July 20, 2023 | finance.yahoo.comBioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital MarketJuly 19, 2023 | finance.yahoo.comBGLC - BioNexus Gene Lab Corp.July 19, 2023 | wsj.comBioNexus Gene Lab Corp.See More Headlines Receive BGLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/02/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:BGLC CUSIPN/A CIK1737523 Webwww.bionexusgenelab.com Phone60-1-2212-6512FaxN/AEmployees27Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,630,000.00 Net Margins-26.90% Pretax Margin-26.69% Return on Equity-32.99% Return on Assets-26.99% Debt Debt-to-Equity RatioN/A Current Ratio4.93 Quick Ratio4.24 Sales & Book Value Annual Sales$9.77 million Price / Sales1.12 Cash FlowN/A Price / Cash FlowN/A Book Value$0.55 per share Price / Book1.12Miscellaneous Outstanding Shares17,790,000Free Float16,576,000Market Cap$10.93 million OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Su-Leng Tan (Age 40)CEO, Acting CFO, Secretary & Director Comp: $16kMr. Kwan Wah ChanMarketing ManagerMr. Too Kam ThamManaging DirectorKey CompetitorsCentogeneNASDAQ:CNTGOpGenNASDAQ:OPGNPsychemedicsNASDAQ:PMDDermTechNASDAQ:DMTKExagenNASDAQ:XGNView All Competitors BGLC Stock Analysis - Frequently Asked Questions How have BGLC shares performed in 2024? BioNexus Gene Lab's stock was trading at $0.53 at the beginning of 2024. Since then, BGLC shares have increased by 15.9% and is now trading at $0.6144. View the best growth stocks for 2024 here. Are investors shorting BioNexus Gene Lab? BioNexus Gene Lab saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 99,700 shares, an increase of 129.7% from the March 31st total of 43,400 shares. Based on an average daily trading volume, of 1,510,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 1.4% of the shares of the company are sold short. View BioNexus Gene Lab's Short Interest. When is BioNexus Gene Lab's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our BGLC earnings forecast. When did BioNexus Gene Lab IPO? BioNexus Gene Lab (BGLC) raised $5 million in an initial public offering (IPO) on Thursday, July 20th 2023. The company issued 1,300,000 shares at $4.00 per share. Network 1 Financial Securities served as the underwriter for the IPO. How do I buy shares of BioNexus Gene Lab? Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BGLC) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
